![Terence Rooney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terence Rooney
Chief Tech/Sci/R&D Officer at
KYMERA THERAPEUTICS, INC.
Net worth: 4 M $ as of 30/07/2026
Profile
Terence Rooney is currently Chief Medical Officer at Kymera Therapeutics, Inc. starting in 2026.
Formerly, Dr. Rooney was Medical Director-Rheumatoid Arthritis at Eli Lilly & Co. Education includes a doctorate from the Royal College of Surgeons.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/07/2026 | 38,000 ( 0.05% ) | 4 M $ | 30/07/2026 |
Terence Rooney active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 26/07/2026 |
Former positions of Terence Rooney
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/01/2020 |
Training of Terence Rooney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Royal College of Surgeons
 Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Stock Market
- Insiders
- Terence Rooney
